Consulting Services
Compare Stocks
2 / 10Stock Comparison
SBC vs LASE
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
SBC vs LASE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Consulting Services | Industrial - Machinery |
| Market Cap | $329M | $16M |
| Revenue (TTM) | $178M | $7M |
| Net Income (TTM) | $43M | $-8M |
| Gross Margin | 73.7% | 31.1% |
| Operating Margin | 33.3% | -126.5% |
| Forward P/E | 7.1x | — |
| Total Debt | $12M | $5M |
| Cash & Equiv. | $125M | $534K |
SBC vs LASE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| SBC Medical Group H… (SBC) | 100 | 32.0 | -68.0% |
| Laser Photonics Cor… (LASE) | 100 | 28.0 | -72.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SBC vs LASE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SBC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.76
- Rev growth 6.1%, EPS growth 15.5%
- -67.8% 10Y total return vs LASE's -72.0%
In this particular matchup, LASE is outpaced on most metrics by others in the set.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.1% revenue growth vs LASE's -13.3% | |
| Quality / Margins | 24.3% margin vs LASE's -105.4% | |
| Stability / Safety | Beta 0.76 vs LASE's 1.68, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +0.3% vs LASE's -74.1% | |
| Efficiency (ROA) | 13.5% ROA vs LASE's -43.1%, ROIC 72.3% vs -42.1% |
SBC vs LASE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SBC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SBC is the larger business by revenue, generating $178M annually — 25.0x LASE's $7M. SBC is the more profitable business, keeping 24.3% of every revenue dollar as net income compared to LASE's -105.4%. On growth, LASE holds the edge at +28.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $178M | $7M |
| EBITDAEarnings before interest/tax | $62M | -$8M |
| Net IncomeAfter-tax profit | $43M | -$8M |
| Free Cash FlowCash after capex | -$37M | -$4M |
| Gross MarginGross profit ÷ Revenue | +73.7% | +31.1% |
| Operating MarginEBIT ÷ Revenue | +33.3% | -126.5% |
| Net MarginNet income ÷ Revenue | +24.3% | -105.4% |
| FCF MarginFCF ÷ Revenue | -20.5% | -58.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -18.3% | +28.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.2% | -7.4% |
Valuation Metrics
LASE leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $329M | $16M |
| Enterprise ValueMkt cap + debt − cash | $216M | $21M |
| Trailing P/EPrice ÷ TTM EPS | 6.65x | -3.29x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.07x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 2.92x | — |
| Price / SalesMarket cap ÷ Revenue | 1.60x | 4.70x |
| Price / BookPrice ÷ Book value/share | 1.59x | 0.90x |
| Price / FCFMarket cap ÷ FCF | 19.17x | — |
Profitability & Efficiency
SBC leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
SBC delivers a 17.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-184 for LASE. SBC carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to LASE's 0.49x. On the Piotroski fundamental quality scale (0–9), SBC scores 7/9 vs LASE's 1/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +17.5% | -183.5% |
| ROA (TTM)Return on assets | +13.5% | -43.1% |
| ROICReturn on invested capital | +72.3% | -42.1% |
| ROCEReturn on capital employed | +37.9% | -45.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 1 |
| Debt / EquityFinancial leverage | 0.06x | 0.49x |
| Net DebtTotal debt minus cash | -$113M | $4M |
| Cash & Equiv.Liquid assets | $125M | $533,871 |
| Total DebtShort + long-term debt | $12M | $5M |
| Interest CoverageEBIT ÷ Interest expense | 596.05x | -6.60x |
Total Returns (Dividends Reinvested)
SBC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SBC five years ago would be worth $3,223 today (with dividends reinvested), compared to $2,805 for LASE. Over the past 12 months, SBC leads with a +0.3% total return vs LASE's -74.1%. The 3-year compound annual growth rate (CAGR) favors SBC at -32.2% vs LASE's -38.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -25.9% | -63.8% |
| 1-Year ReturnPast 12 months | +0.3% | -74.1% |
| 3-Year ReturnCumulative with dividends | -68.9% | -76.6% |
| 5-Year ReturnCumulative with dividends | -67.8% | -72.0% |
| 10-Year ReturnCumulative with dividends | -67.8% | -72.0% |
| CAGR (3Y)Annualised 3-year return | -32.2% | -38.4% |
Risk & Volatility
SBC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SBC is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than LASE's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBC currently trades 55.8% from its 52-week high vs LASE's 10.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 1.68x |
| 52-Week HighHighest price in past year | $5.75 | $6.77 |
| 52-Week LowLowest price in past year | $2.97 | $0.38 |
| % of 52W HighCurrent price vs 52-week peak | +55.8% | +10.7% |
| RSI (14)Momentum oscillator 0–100 | 29.9 | 38.5 |
| Avg Volume (50D)Average daily shares traded | 87K | 1.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | $9.00 | — |
| # AnalystsCovering analysts | 1 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
SBC leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LASE leads in 1 (Valuation Metrics).
SBC vs LASE: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is SBC or LASE a better buy right now?
For growth investors, SBC Medical Group Holdings Incorporated (SBC) is the stronger pick with 6.
1% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). SBC Medical Group Holdings Incorporated (SBC) offers the better valuation at 6. 7x trailing P/E (7. 1x forward), making it the more compelling value choice. Analysts rate SBC Medical Group Holdings Incorporated (SBC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SBC or LASE?
Over the past 5 years, SBC Medical Group Holdings Incorporated (SBC) delivered a total return of -67.
8%, compared to -72. 0% for Laser Photonics Corporation (LASE). Over 10 years, the gap is even starker: SBC returned -67. 8% versus LASE's -72. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SBC or LASE?
By beta (market sensitivity over 5 years), SBC Medical Group Holdings Incorporated (SBC) is the lower-risk stock at 0.
76β versus Laser Photonics Corporation's 1. 68β — meaning LASE is approximately 122% more volatile than SBC relative to the S&P 500. On balance sheet safety, SBC Medical Group Holdings Incorporated (SBC) carries a lower debt/equity ratio of 6% versus 49% for Laser Photonics Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — SBC or LASE?
By revenue growth (latest reported year), SBC Medical Group Holdings Incorporated (SBC) is pulling ahead at 6.
1% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: Laser Photonics Corporation grew EPS 40. 5% year-over-year, compared to 15. 5% for SBC Medical Group Holdings Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SBC or LASE?
SBC Medical Group Holdings Incorporated (SBC) is the more profitable company, earning 22.
7% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps 22. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SBC leads at 34. 2% versus -189. 3% for LASE. At the gross margin level — before operating expenses — SBC leads at 76. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SBC or LASE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is SBC or LASE better for a retirement portfolio?
For long-horizon retirement investors, SBC Medical Group Holdings Incorporated (SBC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
76)). Laser Photonics Corporation (LASE) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SBC: -67. 8%, LASE: -72. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SBC and LASE?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SBC is a small-cap deep-value stock; LASE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.